• Home  
  • Q&A: What is healthcare consolidation and how does it affect patients?
Q&A: What is healthcare consolidation and how does it affect patients?
- Health

Q&A: What is healthcare consolidation and how does it affect patients?

UNIVERSITY PARK, Pa. — The healthcare system in the United States is made up of a complex combination of for-profit businesses, not-for-profit organizations, and public and private sector funding. This multi-payer system operates under the same fundamental principles as profit-maximizing businesses, which can often include decisions around consolidation, mergers and acquisitions, explained Dennis Scanlon, distinguished

UNIVERSITY PARK, Pa. — The healthcare system in the United States is made up of a complex combination of for-profit businesses, not-for-profit organizations, and public and private sector funding. This multi-payer system operates under the same fundamental principles as profit-maximizing businesses, which can often include decisions around consolidation, mergers and acquisitions, explained Dennis Scanlon, distinguished professor of health policy and administration at Penn State.

Scanlon, who also directs the Health Policy Research Lab at Penn State, studies healthcare outcomes and has published dozens of studies on clinical quality, the patient experience and economic efficiency. According to Scanlon, the issues surrounding healthcare consolidation are complex and can impact patients in a variety of ways, from simple branding changes to differences in access to providers and quality of care.

Scanlon recently served as the guest editor for a special edition of the journal Medical Care Research and Review, which focused on healthcare consolidation. He also organized a public meeting in Washington, D.C., to discuss the impacts of consolidation with experts in healthcare, health economics and public policy from across the country. These efforts were intended to disseminate data and research findings, both of which can inform policy and have a direct impact on consumers and society, Scanlon said.

In this Q&A, Scanlon discussed why healthcare consolidation happens, what it means for patients and how to influence change around consolidation-related issues.

Q: What is consolidation in healthcare? Why does it happen?

Scanlon: The answer to this probably depends on who you ask, and, in truth, there could be several answers. Given the complexity of the country’s healthcare system, consolidation happens because insurers, healthcare systems and others see opportunities to better position their economic status through mergers and acquisitions in their industry. This can include both horizontal consolidation — two like entities merging, such as two hospitals — or vertical consolidation — with two different entities in the supply chain merging, such as a hospital and a large multi-specialty physician group.

Arguments for mergers include becoming more efficient by being larger, which can provide cost savings in purchasing and prevent duplicative overhead. Simultaneously, some consolidation occurs because health care entities are failing financially and need to be acquired. Struggling rural hospitals are a common example.

Q: What could consolidation mean to a healthcare consumer and/or a patient?

Scanlon: This can vary from “not much” to very noticeable change. For example, at the minimum, it could play out as a branding change, but with little impact in terms of access to the doctors, nurses and hospitals that provide care for patients, including little disruption to the insurance covering care provided by these services. However, as consolidation has continued to grow in the United States, there has been significant impact for patients on considerations such as which providers are in their available network and eligible for copayments and coinsurance at in- versus out-of-network rates.

Additionally, even if a patient can see the same doctor, many report that care feels different after an acquisition. Some describe it as feeling corporatized by having less time with their physician or non-physician providers or being subject to appointment and billing processes that have changed, which are not always for the better for the patient in terms of access and convenience.

Q: What are the potential outcomes of consolidation in healthcare for consumers and patients? Are there any particular pros and cons?

Scanlon: From a policy and regulatory perspective, this is the key question. Any time that firms want to merge, acquire or consolidate, they will always tell local communities, policymakers and regulators that the result will be better quality care, improved access to care and lower healthcare cost for patients. The evidence can suggest otherwise, however. The national data is quite clear, as it shows prices never go down but instead go up. Data about quality and access are mixed, but the evidence does not overwhelmingly show a positive result.

The implications are higher healthcare prices and costs for patients and families, for employers that provide health insurance benefits to their workers and families, and for state and federal governments that fund Medicaid and Medicare programs.

Most researchers believe that if there are efficiencies that result from consolidation, they go to the consolidating organizations in the form of setting higher prices and margins, rather than reductions in prices and out-of-pocket costs for consumers. Because of this, there is a lot of scrutiny on consolidation. As one analyst said, it is hard to unscramble the eggs, or unwind mergers and acquisitions, after they occur.

Having said this, it was recently announced publicly that CVS Health, which in 2018 combined the Aetna insurance business with the CVS Caremark pharmacy business, will split into two separate publicly traded companies in 2028, in essence unwinding this consolidated entity. Views of the motivation for this unwinding vary, with the company saying it will allow for better and more efficient operation. Skeptics suggest that the company may be trying to get ahead of future additional antitrust scrutiny.

Q: Is there anything consumers and patients can do to influence the direction of healthcare consolidation?

Scanlon: Like any social issue of importance, proposed consolidation in healthcare usually attracts the attention of local communities and generates debate and discourse about the pros and cons of the proposed acquisition or merger. This is an opportunity for consumers and patients to become informed of the reasons for the proposed consolidation, form opinions about the consolidation from their own and various stakeholders’ perspectives and let those opinions be known through the usual public policy process by voicing them to state and federal legislators and regulators.

Ultimately, these decisions are supposed to be based on federal antitrust laws, but there are examples where community opposition has been an important component in stopping consolidation before it happens.

Q: You recently assembled a group of thought leaders on the economics of healthcare at a meeting, sponsored by Penn State, in Washington, D.C., and also served as a guest editor for a journal. What do you hope for the outcomes of that meeting?

Scanlon: Healthcare consolidation impacts healthcare spending for patients, families, employers and government-sponsored social programs. Money is tight for all these individuals and entities, and they should pay fair, efficient prices, but not have to pay more than that. Research and analysis can provide important data and information about the impact of consolidation, including its new forms being funded by private equity arrangements, which are hard to track.

Meetings like this are a non-contentious way to bring all perspectives to the table and keep stakeholders up to date on new developments and key issues. Anyone who is interested in information and issues concerning healthcare consolidation can access the meeting content online.

A unique aspect of this meeting was the breadth of knowledge of the attendees. We hosted not only academic researchers but also providers from healthcare systems and communities, insurance company representatives, labor union representatives from the American Federation of Labor and Congress of Industrial Organizations, and regulators from federal antitrust authorities, including the Federal Trade Commission and the Department of Justice. We were also joined by policy representatives from several states, including Pennsylvania and Massachusetts, and there were well over 200 attendees virtually.

The meeting was informed by a special edition of the journal Medical Care Research and Review, for which I served as a guest editor. Ultimately, by providing data and research, experts can contribute important information that can hopefully have a positive impact on individuals and society.

Source: www.psu.edu

About Us

Toolq Media Is a Global News Platform Covering the Latest Developments and Breaking Stories from Around The World, Including World News, Business, Finance, Technology, Health, Politics, Science, Entertainment, Sports, and More.

Toolq

Toolq @2026. All Rights Reserved.